Yes George, JD says that more deals are in the pipeline and they need the manufacturing expansion to cope with demand. I think the valuation will be much higher later in the year.
The initial data from Sunrise - pd is excellent at the lowest dose. higher dose to be given in May.
If efficacy improves it could be a game changer in Parkinson`s.
News 
Market Data 
Discover 
AI
